ID   A549 BLTP3A-V5 clone B6
AC   CVCL_E9W3
RX   DOI=10.1101/2024.09.28.615015;
CC   Population: Caucasian.
CC   Characteristics: Using CRISPR/Cas9 a V5 tag was introduced just after p.Val904 of both alleles of BLTP3A (DOI=10.1101/2024.09.28.615015).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Ser (c.34G>A); ClinVar=VCV000012584; Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11389; STK11; Simple; p.Gln37Ter (c.109C>T); ClinVar=VCV000376334; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Lung; UBERON=UBERON_0002048.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0023 ! A-549
SX   Male
AG   58Y
CA   Cancer cell line
DT   Created: 14-08-25; Last updated: 14-08-25; Version: 1
//
RX   DOI=10.1101/2024.09.28.615015;
RA   Hanna, Michael George 4th
RA   Rodriguez-Cruz, Hely Octavio
RA   Fujise, Kenshiro
RA   Wu, Yu-Mei
RA   Xu, C. Shan
RA   Pang, Song
RA   Li, Zhuon-Ging
RA   Monetti, Mara
RA   De Camilli, Pietro
RT   "BLTP3A is associated with membranes of the late endocytic pathway and
RT   is an effector of CASM.";
RL   bioRxiv 2024:09.28.615015-09.28.615015(2024).
//